InMed Pharmaceuticals (INM) Competitors $2.75 -0.07 (-2.48%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.73 -0.02 (-0.73%) As of 07/11/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock INM vs. IMNN, RLYB, SYBX, AIMD, TXMD, TRIB, NKGN, FLGC, NEUP, and MEShould you be buying InMed Pharmaceuticals stock or one of its competitors? The main competitors of InMed Pharmaceuticals include Imunon (IMNN), Rallybio (RLYB), Synlogic (SYBX), Ainos (AIMD), TherapeuticsMD (TXMD), Trinity Biotech (TRIB), NKGen Biotech (NKGN), Flora Growth (FLGC), Neuphoria Therapeutics (NEUP), and 23andMe (ME). These companies are all part of the "pharmaceutical products" industry. InMed Pharmaceuticals vs. Its Competitors Imunon Rallybio Synlogic Ainos TherapeuticsMD Trinity Biotech NKGen Biotech Flora Growth Neuphoria Therapeutics 23andMe InMed Pharmaceuticals (NASDAQ:INM) and Imunon (NASDAQ:IMNN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings. Which has more volatility and risk, INM or IMNN? InMed Pharmaceuticals has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Imunon has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Is INM or IMNN more profitable? Imunon has a net margin of 0.00% compared to InMed Pharmaceuticals' net margin of -168.87%. InMed Pharmaceuticals' return on equity of -107.93% beat Imunon's return on equity.Company Net Margins Return on Equity Return on Assets InMed Pharmaceuticals-168.87% -107.93% -82.97% Imunon N/A -427.98%-175.03% Does the media refer more to INM or IMNN? In the previous week, InMed Pharmaceuticals and InMed Pharmaceuticals both had 1 articles in the media. Imunon's average media sentiment score of 1.89 beat InMed Pharmaceuticals' score of 0.94 indicating that Imunon is being referred to more favorably in the news media. Company Overall Sentiment InMed Pharmaceuticals Positive Imunon Very Positive Do institutionals & insiders believe in INM or IMNN? 20.1% of InMed Pharmaceuticals shares are held by institutional investors. Comparatively, 4.5% of Imunon shares are held by institutional investors. 1.4% of InMed Pharmaceuticals shares are held by company insiders. Comparatively, 6.0% of Imunon shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, INM or IMNN? InMed Pharmaceuticals has higher revenue and earnings than Imunon. Imunon is trading at a lower price-to-earnings ratio than InMed Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMed Pharmaceuticals$4.60M0.72-$7.68M-$12.09-0.23Imunon$500K21.23-$18.62M-$1.36-0.44 Do analysts rate INM or IMNN? Imunon has a consensus price target of $15.50, indicating a potential upside of 2,461.56%. Given Imunon's stronger consensus rating and higher probable upside, analysts clearly believe Imunon is more favorable than InMed Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMed Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Imunon 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75 SummaryImunon beats InMed Pharmaceuticals on 10 of the 16 factors compared between the two stocks. Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INM vs. The Competition Export to ExcelMetricInMed PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.32M$2.42B$5.55B$9.09BDividend YieldN/A1.81%5.07%4.03%P/E Ratio-0.239.2228.2520.31Price / Sales0.72727.94433.2199.68Price / CashN/A22.3426.2427.98Price / Book0.134.638.125.50Net Income-$7.68M$30.99M$3.19B$250.38M7 Day Performance-5.17%4.80%3.62%4.79%1 Month Performance8.70%8.17%5.98%9.59%1 Year Performance-48.11%-3.88%29.39%16.41% InMed Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMInMed Pharmaceuticals0.3486 of 5 stars$2.75-2.5%N/A-48.1%$3.32M$4.60M-0.2310Gap DownIMNNImunon2.4767 of 5 stars$0.73-7.6%$15.50+2,023.3%-57.7%$13.86MN/A-0.5430Positive NewsRLYBRallybio2.6414 of 5 stars$0.34+2.3%$10.00+2,837.7%-70.6%$13.85M$848K-0.3140News CoverageGap DownSYBXSynlogic1.1622 of 5 stars$1.19+0.8%N/A-17.8%$13.80M$10K-0.4780Positive NewsGap DownAIMDAinos1.5471 of 5 stars$3.30+0.3%N/A-25.5%$13.79M$20K-0.5140TXMDTherapeuticsMD0.8611 of 5 stars$1.17-0.8%N/A-36.2%$13.66M$1.76M0.00420Positive NewsTRIBTrinity Biotech1.1629 of 5 stars$0.73-2.0%N/A-76.0%$13.54M$61.56M-0.26480NKGNNKGen Biotech0.2713 of 5 stars$0.30flatN/A-68.7%$13.48MN/A-0.06N/ANews CoverageGap UpFLGCFlora Growth2.4857 of 5 stars$0.58-1.9%$4.00+584.9%-36.6%$13.43M$59.51M-0.60280Positive NewsNEUPNeuphoria Therapeutics2.2426 of 5 stars$7.16+0.4%$21.00+193.3%N/A$13.40M$10K0.00N/AME23andMeN/A$0.50-35.3%N/A-94.8%$13.36M$208.78M-0.03770Gap DownHigh Trading Volume Related Companies and Tools Related Companies IMNN Alternatives RLYB Alternatives SYBX Alternatives AIMD Alternatives TXMD Alternatives TRIB Alternatives NKGN Alternatives FLGC Alternatives NEUP Alternatives ME Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INM) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INM Stock Alerts